Canna Care Docs

NOVEMBER 4, 2024

Common treatments for chronic pain can include: Pharmaceuticals (painkillers, anti-inflammatories) Physical therapy Lifestyle changes (exercise, diet) Despite medical advancements, many patients find these methods still don’t offer adequate relief. These cannabinoids work directly with the body’s endocannabinoid system (ECS).

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Canna Law Blog

FEBRUARY 21, 2020

Last week, the Food Standard Agency (“ FSA ”), the agency responsible for protecting public health in relation to food in England, Wales and Northern Ireland (collectively, the “UK”), cleared a path for the sale of CBD-infused food for the next 12 months. The EFSA guidance on cannabinoids strongly echoes the U.S.

Food 117

Food CBD Legalization Hemp 117

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Law Report

JULY 26, 2021

VANCOUVER, British Columbia, July 26, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co Ltd., ( CSE: CRFT ) (“ CRFT ” or the “ Company ”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce that its subsidiary, FeelWell Brands Inc. About BC Craft Supply Co Ltd.

Events 105

Events Cannabinoids Advocacy Cannabis 105

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

MAY 29, 2021

. “At the same time – underlines Gallinella -, I asked AIFA , the Italian Medicines Agency, to make known the list of potentially suitable pharmaceutical workshops so that the agricultural companies concerned can get in touch to start, together, the complex authorization process at the Ministry della Salute which, to date, has only (..)

Extraction 78

Extraction Agriculture Cultivation Pharmaceutical 78

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Furthermore, THC and CBD may have a synergistic effect.

Data 114

Data Chronic Pain Sleep Patients 114

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 22, 2019

On April 22, 2019, United Nations-based cannabis correspondent and global drug policy analyst Sara Brittany Somerset took advantage of our collective national climate focus to address the “ cannabis carbon footprint ” issue with her pertinent Earth Day Begs The Question: Is Cannabis Farming Sustainable?

Packaging 74

Packaging Seed-To-Sale Agriculture Environment 74

Cannabis Law Report

MARCH 26, 2022

The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI), and First November Group, recently announced the launch of a new wide-ranging commission to review regulation and public policy in the United Kingdom’s (UK) legal cannabis industry called the Hodges Review.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52

Veriheal

JANUARY 25, 2022

Because of the federal legality of these products—and because the Minnesota State Legislature had previously passed a law that made non-food products containing nonintoxicating cannabinoids legal—the CBD industry in Minnesota had taken off in recent years. Now, an estimated 85% of hemp products currently sold in the state are illegal.

Hemp 98

Hemp Business CBD Seed-To-Sale 98

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. A medical provider may recommend medical cannabis to treat any condition that they feel may benefit from medical cannabis and cannabinoid-based therapies.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

MAY 8, 2022

I have an extensive background in healthcare and have worked in the community, aged care and palliative care sectors as well the corporate (pharmaceutical and insurance) sectors. I am the founder of the ECS Wellness Collective.

Education 98

Education Medicine Cannabinoids Programs 98

Veriheal

SEPTEMBER 23, 2021

Current statistics from the Anthenum Collective show that more than 67% of Americans believe cannabis should be legal, and legal cannabis sales are expected to achieve a value of $73.6 As the fight for legalization continues across the nation, more and more entrepreneurs are jumping for a spot in the flourishing industry.

Business 98

Business Access Cannabis Therapy 98

Puff Puff Post

MAY 28, 2019

Now that CBD oil is becoming widely available, many sleep sufferers are flocking to the cannabinoid to save their sleep without getting high. Her previous use of pharmaceutical medications provided only minor relief that came with a slew of side-effects. The body contains two types of cannabinoid receptors, CB1 and CB2.

Sleep 18

Sleep Oil CBD Tincture 18

Cannabis Law Report

OCTOBER 25, 2021

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has received the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). Cosechemos Operational Update.

Agriculture 40

Agriculture Collective Pharmaceutical Cultivation 40

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Cannabis Law Report

FEBRUARY 2, 2022

– Flora’s research division, Flora Pharma, files USPTO provisional patent application on a cannabinoid-based formula. – Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA).

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Puff Puff Post

SEPTEMBER 24, 2019

The scientific properties of the plant remained elusive and mysterious until Dr. Raphael Mechoulam and his team of researchers discovered and isolated specific molecules within the cannabis plant called “phytocannabinoids” or simply, plant cannabinoids. . In the ECS, the “keys” are referred to as endogenous cannabinoids. .

History 94

History Cannabinoids Indica Tincture 94

Cannabis Law Report

APRIL 28, 2022

DEMECAN’s first cannabis shipment to the BfArM is ready for collection and includes more than 100 kg of cannabis flowers. Over 100 kg of these will be made available for collection on April 20 by the federal cannabis agency and for distribution to pharmacies. 2500 cannabis plants are now growing in its own flower rooms in Saxony.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

SEPTEMBER 16, 2022

The university’s Lambert Initiative for Cannabinoid Therapeutics is launching its flagship CAN-ACT study of ACT residents who grow, possess, and use small quantities of cannabis for both medicinal and non-medicinal purposes. The CAN-ACT study is being funded by the Lambert Initiative for Cannabinoid Therapeutics, University of Sydney.

Cultivation 52

Cultivation Pharmaceutical Cannabinoids Medicine 52

Leaf Science

JULY 24, 2019

No, the real obstacle to our inevitable shift to health and prosperity is, in the irony of all ironies, “pharmaceutical” and other powerful groups who have an interest in maintaining the sickly status quo. The more acceptable it becomes the more collective benefits we receive. The more we grow, the more acceptable cannabis will become.

Sativa 19

Sativa Hemp Cannabis Pharmaceutical 19

Cannabis Law Report

NOVEMBER 27, 2019

As Folium launches “Truth in Hemp ,” the need for safe, high quality, truthful Cannabinoid products has never been greater for the public. There is no other Cannabinoid company positioned to compete with our core capabilities of quality, science, scale, and innovation. Here’s the opening gambit.

Hemp 45

Hemp Cannabinoids Supply Chain Pharmaceutical 45

Cannabis Law Report

JULY 28, 2021

Additionally, as previously announced on January 21, 2021, Unifor and Aleafia entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents that receive medical cannabis insurance coverage clinics through Unifor’s collective bargaining agreements. The recent addition of KGK Science Inc.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

MARCH 22, 2020

Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

JUNE 29, 2022

Pure Hemp Collective, Inc. In July of 2018, United Cannabis Corporation (“UCANN”) filed an infringement action against Pure Hemp Collective (“Pure Hemp”) in the United States District Court District of Colorado. Patent 1 , which claims various liquid formulations of enriched extracts of plant cannabinoids.

Research and Development 52

Research and Development Extraction Pharmaceutical Hemp 52

Cannabis Law Report

FEBRUARY 15, 2022

A liquid nanoemulsion is the gold standard for food and beverage formulations infused with cannabinoids like THC or CBD. This small business has extraordinary ability, expertise, and intellectual property usually reserved for billion dollar pharmaceutical or public corporations. the_art_and_science_of_cannabis_powder.

Research and Development 52

Research and Development Trichome Digestion Edibles 52

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. Moreover much of the research done has focused on synthetic pharmaceutical grade cannabinoids developed by pharmaceutical companies.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. To learn more, please visit www.radiclescience.com and follow their LinkedIn page. About Open Book Extracts. Headquartered in Roxboro, N.C.,

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

CannaTech

APRIL 1, 2019

Since medical cannabis has been prescribed for a range of indications since the late 1990s, there are years of data from large cohorts of patients treated with pharmaceutical-grade cannabis. Eybna’s location in Israel proffers the unique benefit of a long-standing legal medical cannabis infrastructure. What are some of these partnerships?

Research and Development 60

Research and Development Terpenes Data Strains 60

Cannabis Law Report

NOVEMBER 22, 2019

21, 2019 (GLOBE NEWSWIRE) — Clever Leaves , a leading vertically-integrated licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has received a pre-license letter from INFARMED I.P., million square feet of greenhouses under Good Agricultural and Collection Practices (GACP) in Colombia. NEW YORK, Nov.

Cultivation 9

Cultivation Extraction Pharmaceutical Research and Development 9

Cannabis Law Report

SEPTEMBER 3, 2019

(TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. Gaining Momentum in Australia: Facility Construction Update.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 billion in legal U.S. Motion sickness.

THC 52

THC CBD Treatment Cannabinoids 52

Cannabis Law Report

OCTOBER 21, 2021

The inaugural collection for Munzhi includes 12 products across four categories: Wellness, Hair, Body, and Face. The collection combines the benefits of cannabidiol (“CBD”) as an active ingredient, with other plant-based ingredients such as lavender oil and chamomile coconut amongst others.”. About Flora Growth Corp.

Wellness and Beauty 40

Wellness and Beauty Research and Development Events Pharmaceutical 40